Rockefeller Capital Management L.P. Sells 232,636 Shares of Omnicell, Inc. $OMCL

Rockefeller Capital Management L.P. trimmed its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL) by 90.6% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 24,176 shares of the company’s stock after selling 232,636 shares during the period. Rockefeller Capital Management L.P.’s holdings in Omnicell were worth $711,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Omnicell during the 1st quarter valued at about $2,073,000. GSA Capital Partners LLP bought a new stake in Omnicell in the first quarter valued at approximately $901,000. XTX Topco Ltd boosted its stake in shares of Omnicell by 316.1% during the first quarter. XTX Topco Ltd now owns 30,295 shares of the company’s stock valued at $1,059,000 after purchasing an additional 23,015 shares during the period. Arkadios Wealth Advisors grew its holdings in shares of Omnicell by 7.5% in the first quarter. Arkadios Wealth Advisors now owns 46,705 shares of the company’s stock worth $1,633,000 after purchasing an additional 3,251 shares during the last quarter. Finally, New Age Alpha Advisors LLC bought a new position in shares of Omnicell in the first quarter worth approximately $233,000. Hedge funds and other institutional investors own 97.70% of the company’s stock.

Omnicell Stock Performance

NASDAQ:OMCL opened at $36.66 on Thursday. The company has a quick ratio of 1.24, a current ratio of 1.42 and a debt-to-equity ratio of 0.13. The firm’s fifty day simple moving average is $32.45 and its 200 day simple moving average is $30.94. The stock has a market cap of $1.65 billion, a P/E ratio of 73.32, a price-to-earnings-growth ratio of 6.29 and a beta of 0.95. Omnicell, Inc. has a twelve month low of $22.66 and a twelve month high of $48.67.

Analyst Upgrades and Downgrades

A number of research firms recently commented on OMCL. Benchmark upped their price target on shares of Omnicell from $40.00 to $45.00 and gave the company a “buy” rating in a report on Friday, October 31st. Wall Street Zen lowered shares of Omnicell from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 9th. Piper Sandler lowered their price objective on shares of Omnicell from $57.00 to $55.00 and set an “overweight” rating for the company in a research note on Monday, August 11th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Omnicell in a report on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $42.00.

Insider Buying and Selling at Omnicell

In related news, EVP Corey J. Manley sold 3,880 shares of the business’s stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $33.25, for a total transaction of $129,010.00. Following the transaction, the executive vice president owned 110,653 shares in the company, valued at $3,679,212.25. The trade was a 3.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.52% of the company’s stock.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.